During the past decade, Hadassah Ein Karem Hospital; Haematology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 4 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hadassah Ein Karem Hospital; Haematology" are "Chronic Lymphocytic Leukemia" (1 trials), "Leukemia, Myeloid, Acute" (1 trials), "Lymphocytic Leukemia, Chronic" (1 trials), "Non-Hodgkin's Lymphoma" (1 trials) and "Non-Hodgkins Lymphoma" (1 trials). Many other conditions were trialed in "Hadassah Ein Karem Hospital; Haematology" in a lesser frequency.

Most popular intervention types in "Hadassah Ein Karem Hospital; Haematology" are "Drug" (5 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (2 trials), "Fludarabine" (2 trials), "Obinutuzumab" (2 trials), "89Zr-Df-IAB22M2C" (1 trials) and "Atezolizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hadassah Ein Karem Hospital; Haematology" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Hadassah Ein Karem Hospital; Haematology". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Hadassah Ein Karem Hospital; Haematology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hadassah Ein Karem Hospital; Haematology, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".